-transparent.png){kind=logo}
Eleven insulin-dependent ketosis-prone diabetics were given glibenclamide (5 mg/day) in addition to their usual insulin treatment for a period of 1 or 6 mo. There was significant reduction in arginine-induced IRG and hGH secretion and no change in blood glucose levels after either 1 or 6 mo of treatment. During that time no change in weight or insulin requirement was observed. The importance of the duration of treatment and the fact that in this type of patient the effects on IRG and hGH secretion could not be mediated by the influence on insulin secretion are stressed.
Related Publications
F Fallucca, and
M Iavicoli, and
G Menzinger, and
C Mirabella, and
D Andreani
April 1976,
Obstetrics and gynecology,
F Fallucca, and
M Iavicoli, and
G Menzinger, and
C Mirabella, and
D Andreani
August 1972,
Lancet (London, England),
F Fallucca, and
M Iavicoli, and
G Menzinger, and
C Mirabella, and
D Andreani
April 1981,
European journal of clinical investigation,
F Fallucca, and
M Iavicoli, and
G Menzinger, and
C Mirabella, and
D Andreani
January 1968,
Acta diabetologica latina,
F Fallucca, and
M Iavicoli, and
G Menzinger, and
C Mirabella, and
D Andreani
October 1968,
Acta diabetologica latina,
F Fallucca, and
M Iavicoli, and
G Menzinger, and
C Mirabella, and
D Andreani
July 1974,
Horumon to rinsho. Clinical endocrinology,
F Fallucca, and
M Iavicoli, and
G Menzinger, and
C Mirabella, and
D Andreani
June 1983,
Clinical endocrinology,
F Fallucca, and
M Iavicoli, and
G Menzinger, and
C Mirabella, and
D Andreani
August 1986,
British medical journal (Clinical research ed.),
F Fallucca, and
M Iavicoli, and
G Menzinger, and
C Mirabella, and
D Andreani
January 1988,
Acta endocrinologica,
F Fallucca, and
M Iavicoli, and
G Menzinger, and
C Mirabella, and
D Andreani
May 1981,
The Journal of clinical endocrinology and metabolism,
